Biofrontera AG
BFFTF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 18.8% | 19% | 27.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 48.8% | 47% | 47.1% | 51.9% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -54.2% | 3.3% | -152.5% | -39.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -59.1% | -2.2% | -156.5% | -58.3% |
| EPS Diluted | -13.02 | -0.61 | -44.1 | -18.94 |
| % Growth | -2,034.4% | 98.6% | -132.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |